ASP-2408
- Generic Name
- ASP-2408
A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections
Phase 1
Completed
- Conditions
- Pharmacokinetics of ASP2408Healthy Subjects
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2014-05-29
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT02150070
- Locations
- 🇺🇸
Parexel International, Baltimore, Maryland, United States
A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2014-07-01
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 24
- Registration Number
- NCT02140125
A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy SubjectsPharmacokinetics of ASP2408
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-04-29
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT02125435
- Locations
- 🇺🇸
PAREXEL International, Baltimore, Maryland, United States
A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate
Phase 1
Completed
- Conditions
- Pharmacokinetics of ASP2408Rheumatoid Arthritis
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- Astellas Pharma Global Development, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02052375
- Locations
- 🇺🇸
Pinnacle Research Group, LLC, Anniston, Alabama, United States
🇺🇸Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States
🇺🇸Metroplex Clinical Research Center, LLC, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath